Significance of HIF-1-active cells in angiogenesis and radioresistance.

作者: H Harada , S Kizaka-Kondoh , G Li , S Itasaka , K Shibuya

DOI: 10.1038/SJ.ONC.1210556

关键词:

摘要: Human solid tumors contain hypoxic regions that have considerably lower oxygen tension than the normal tissues. Hypoxia offers resistance to radiotherapy and anticancer chemotherapy, as well predispose increased tumor metastases. Furthermore, hypoxia induces hypoxia-inducible factor-1 (HIF-1), which in turn increases angiogenesis. Thus, eradication of HIF-1-active/hypoxic cells is very important for cancer therapy. We previously reported procaspase-3 fused with a von Hippel–Lindau (VHL)-mediated protein destruction motif alpha subunit HIF-1 (HIF-1α) containing Pro564, named TAT-ODD-procaspase-3 (TOP3), specifically induced cell death vivo vitro. now report TOP3 also eradicates radiation-induced HIF-1-active cells. activity xenografts human cells, express luciferase under transcriptional control HIF-1, were monitored quantified daily an bioluminescence photon-counting device. was more rapidly by ionizing radiation (IR) compared untreated tumors. efficiently decreased HIF-1-activity irradiated unirradiated ones, indicating eradicated IR hypoxia. Eradication during irradiation exhibited significant suppression angiogenesis strong enhancement long-term growth xenografts. These results further strengthen argument play crucial roles radioresistance.

参考文章(38)
Adrian L. Harris, Hypoxia — a key regulatory factor in tumour growth Nature Reviews Cancer. ,vol. 2, pp. 38- 47 ,(2002) , 10.1038/NRC704
Halina Oshinka, Ling Geng, Edwin Donnelly, P. Charles Lin, Elaine Sierra-Rivera, Dennis E. Hallahan, Gerald McMahon, Inhibition of Vascular Endothelial Growth Factor Receptor Signaling Leads to Reversal of Tumor Resistance to Radiotherapy Cancer Research. ,vol. 61, pp. 2413- 2419 ,(2001)
Lynn Hlatky, Philip Hahnfeldt, Thuy Trinh, Robert Krempien, Amir Abdollahi, Klaus J. Weber, Kenneth E. Lipson, Xiaohong Han, Juergen Debus, Juergen Debus, Peter E. Huber, Anthony R. Howlett, SU5416 and SU6668 Attenuate the Angiogenic Effects of Radiation-induced Tumor Cell Growth Factor Production and Amplify the Direct Anti-endothelial Action of Radiation in Vitro Cancer Research. ,vol. 63, pp. 3755- 3763 ,(2003)
Friedrich Kallinowski, Paul Okunieff, Peter Vaupel, Blood Flow, Oxygen and Nutrient Supply, and Metabolic Microenvironment of Human Tumors: A Review Cancer Research. ,vol. 49, pp. 6449- 6465 ,(1989)
Keiji Tanimoto, Yuichi Makino, Teresa Pereira, Lorenz Poellinger, Mechanism of regulation of the hypoxia‐inducible factor‐1α by the von Hippel‐Lindau tumor suppressor protein The EMBO Journal. ,vol. 19, pp. 4298- 4309 ,(2000) , 10.1093/EMBOJ/19.16.4298
Masahiro Inoue, Mutsuko Mukai, Yukou Hamanaka, Masaharu Tatsuta, Masahiro Hiraoka, Shinae Kizaka-Kondoh, Targeting hypoxic cancer cells with a protein prodrug is effective in experimental malignant ascites. International Journal of Oncology. ,vol. 25, pp. 713- 720 ,(2004) , 10.3892/IJO.25.3.713
Björn Zackrisson, Claes Mercke, Hans Strander, Johan Wennerberg, Eva Cavallin-ståhl, A systematic overview of radiation therapy effects in head and neck cancer. Acta Oncologica. ,vol. 42, pp. 443- 461 ,(2003) , 10.1080/02841860310014886
J. Martin Brown, William R. Wilson, Exploiting tumour hypoxia in cancer treatment. Nature Reviews Cancer. ,vol. 4, pp. 437- 447 ,(2004) , 10.1038/NRC1367